日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biomarkers in individualized management of chimeric antigen receptor T cell therapy

嵌合抗原受体T细胞疗法个体化管理中的生物标志物

Du, Mengyi; Hari, Parameswaran; Hu, Yu; Mei, Heng

The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients

年龄对新诊断多发性骨髓瘤患者自体造血干细胞移植后生存率和超额死亡率的影响

Mizuno, Shohei; Gras, Luuk; Baaij, Laurien G A; Koster, Linda; D'Souza, Anita; Hari, Parameswaran N; Estrada-Merly, Noel; Saber, Wael; Cowan, Andrew J; Iida, Minako; Okamoto, Shinichiro; Takamatsu, Hiroyuki; Kawamura, Koji; Kodera, Yoshihisa; Hamad, Nada; Ko, Bor-Sheng; Liam, Christopher; Ho, Kim Wah; Goh, Ai Sim; Keat, Tan Sui; Elhaddad, Alaa M; Bazarbachi, Ali; Chaudhry, Brig Qamar Un N; Alfar, Rozan; Bekadja, Mohamed Amine; Benakli, Malek; Ortiz, Cristobal Augusto Frutos; Riva, Eloisa; Verburgh, Estelle; Galeano, Sebastian; Bass, Francisca; Mian, Hira; McCurdy, Arleigh; Wang, Feng Rong; Neumann, Daniel; Koh, Mickey Boon Chai; Snowden, John A; Schönland, Stefan; McLornan, Donal P; Hayden, Patrick J; Balari, Anna Maria Sureda; Greinix, Hildegard T; Aljurf, Mahmoud; Atsuta, Yoshiko; Rondelli, Damiano; Niederwieser, Dietger W; Garderet, Laurent

Fine Mapping of MHC Region Identifies Novel Susceptibility Loci in Multiple Myeloma When Comparing With Its Precursor Monoclonal Gammopathy of Unknown Significance

与前体单克隆丙种球蛋白病相比,MHC区域的精细定位鉴定出多发性骨髓瘤的新易感基因位点

Arsang-Jang, Shahram; Massat, Ben; Pareek, Gokul; Han, Jing; Thapa, Bicky; Patek, Victoria; Nader, Zeina; Auer, Paul L; Zimmerman, Michael T; Urrutia, Raul; Hari, Parameswaran; D'Souza, Anita; Dhakal, Binod; Janz, Siegfried; Dong, Jing

Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History

针对伴有抑制剂病史的血友病A的血小板靶向基因治疗

Eapen, Mary; Malec, Lynn M; Armant, Myriam A; Johnson, Bryon D; Shi, Qizhen; Xu, Huiqing; Du, Lily M; Jerkins, James H; Duffy, Lisa J; Bushman, Frederic D; Lee, Carole; Petrichenko, Angelina; Hematti, Peiman; Brazauskas, Ruta; Jobe, Shawn M; Hari, Parameswaran N; Wilcox, David A

Randomized Phase III SIERRA Trial of (131)I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML

随机III期SIERRA试验,比较异基因造血干细胞移植前使用(131)I-阿帕米司单抗与常规治疗复发/难治性急性髓系白血病的疗效

Gyurkocza, Boglarka; Nath, Rajneesh; Seropian, Stuart; Choe, Hannah; Litzow, Mark R; Abboud, Camille; Koshy, Nebu; Stiff, Patrick; Tomlinson, Benjamin; Abhyankar, Sunil; Foran, James; Hari, Parameswaran; Chen, George; Al-Kadhimi, Zaid; Kebriaei, Partow; Sabloff, Mitchell; Orozco, Johnnie J; Jamieson, Katarzyna; Silverman, Margarida; Van Besien, Koen; Schuster, Michael; Law, Arjun Datt; Larkin, Karilyn; Pandit-Taskar, Neeta; Rowley, Scott D; Munshi, Pashna; Cook, Rachel; Levy, Moshe Y; Lazarus, Hillard M; Sandmaier, Brenda M; Pagel, John M; Reddy, Vijay; MacDougall, James; McNamara, Kathleen; Spross, Jennifer; Haeuber, Elaina; Vusirikala, Madhuri; Nahar, Akash; Desai, Avinash; Giralt, Sergio

Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19.

重症 COVID-19 患者体内针对刺突蛋白受体结合域的促血栓抗体

Zhu Wen, Zheng Yongwei, Yu Mei, Witman Nathan, Zhou Lu, Wei Jianhui, Zhang Yongguang, Topchyan Paytsar, Nguyen Christine, Wang David, Janecke Rae, Padmanabhan Anand, Baumann Kreuziger Lisa, White Gilbert C, Hari Parameswaran, Gu Tongjun, Fields Alexander T, Kornblith Lucy Z, Aster Richard, Zhu Jieqing, Cui Weiguo, Jobe Shawn, Graham Mary Beth, Wang Demin, Wen Renren

Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma

雷帕霉素耐药的多克隆Th1/Tc1细胞疗法(RAPA-201)可安全地诱导复发难治性多发性骨髓瘤的疾病缓解。

Dhakal, Binod; Hari, Parameswaran; Chhabra, Saurabh; Szabo, Aniko; Lum, Lawrence G; Glass, Deborah D; Park, Jee Hyun; Donato, Michele; Siegel, David S; Felizardo, Tania C; Fowler, Daniel H

Allogeneic versus autologous stem cell transplantation after relapsing following first line autologous transplantation for multiple myeloma: A systematic review

多发性骨髓瘤一线自体移植后复发患者异基因与自体干细胞移植的比较:系统评价

Ludwig, Heinz; Bernhard, Sarah; Ikeda, Takashi; Freytes, Cesar O; Schreder, Martin; Kawamura, Koji; Atsuta, Yoshiko; Takamatsu, Hiroyuki; Vesole, David H; Hari, Parameswaran; Krainer, Julie; Hinke, Axel

Predictors of mortality among critically ill SARS-CoV-2 infected patients-a retrospective cohort study, Kerala, India

印度喀拉拉邦:SARS-CoV-2重症感染患者死亡率的预测因素——一项回顾性队列研究

Sathyadas, Anil; Reghukumar, Aravind; Anish, Thekkumkara Surendran; Libu, Gnanaseelan Kanakamma; Kiran, Vishnu Narayan; Prajitha, Kannamkottapilly Chandrasekharan; Sharahudeen, Anisha; Chandran, Dhanusha; Athirarani, Muralidharan Rohini; Sindhu, L; Sona, Parackalparambil Sukumaran; Sreekanth, Thekkumkara Prabhakaran; Chintha, Sujatha; Iype, Thomas; Suresh, Muthezhathu Kesavadas; Ravi, Kavitha; Rajamohanan, K; Mathew, Thomas; Panicker, John; Nair, M K C; Nizarudeen, A; Hari, Parameswaran

Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival

自体造血干细胞移植和来那度胺维持治疗1年后多发性骨髓瘤的微小残留病灶状态与长期总生存期相关

Pasquini, Marcelo C; Wallace, Paul K; Logan, Brent; Kaur, Manmeet; Tario, Joseph D; Howard, Alan; Zhang, Yali; Brunstein, Claudio; Efebera, Yvonne; Geller, Nancy; Giralt, Sergio; Hari, Parameswaran; Horowitz, Mary M; Koreth, John; Krishnan, Amrita; Landau, Heather; Somlo, George; Shah, Nina; Stadtmauer, Edward; Vogl, Dan T; Vesole, David H; McCarthy, Philip L; Hahn, Theresa